Last reviewed: July 1, 2026
Last updated: July 1, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide dosing follows a structured escalation protocol designed to minimize side effects while maximizing weight loss effectiveness. Most patients begin at 0.25 mg weekly and advance through dose levels over 16 to 20 weeks, with individual responses determining the optimal maintenance dose. PlexusDx delivers compounded semaglutide from licensed 503A pharmacies at a flat monthly price, meaning your dose may need to go up—but your price won't.
How Semaglutide Dosing Works in Clinical Practice
Semaglutide belongs to a drug class called GLP-1 receptor agonists, which regulate appetite and blood sugar through natural hormonal pathways. The medication requires a gradual dose escalation because the body needs time to adapt to its effects. Starting doses of 0.25 mg allow your system to acclimate before advancing, typically by 0.25 mg increments every 4 weeks. This stepwise approach has been proven in clinical trials to improve tolerability and long-term adherence compared to faster dose advancement schedules.
The typical dose progression moves from 0.25 mg to 0.5 mg to 1.0 mg and finally to 2.0 mg weekly, with each step lasting approximately 4 weeks. However, not every patient follows this exact ladder—some reach therapeutic benefit at lower doses, while others may advance to 2.4 mg or higher for maximum effect. Your prescriber monitors your response, including weight loss progress and tolerance to side effects, to determine whether dose increases are necessary. This personalized approach ensures you receive the dose that works best for your metabolism and goals, not an arbitrary standard.
Common Dose Ranges and Patient Outcomes
Clinical trials show that maintenance doses between 1.0 mg and 2.4 mg weekly produce the most significant weight loss results, with average reductions of 15 to 22 percent of body weight over 68 weeks. Many patients achieve substantial results at 1.0 mg or 1.7 mg weekly, the doses used in many published efficacy studies. Doses above 2.4 mg have been studied but are typically reserved for research settings or specific medical situations. The variability in effective doses reflects the fact that genetics, body composition, and individual GLP-1 receptor sensitivity all influence how your body responds.
Some patients experience meaningful appetite suppression and consistent weight loss at lower maintenance doses like 0.5 mg or 1.0 mg weekly. Others require the full 2.4 mg dose to reach their weight loss targets. This dose variability is completely normal and does not indicate treatment failure at lower doses—it simply reflects individual differences in medication metabolism and receptor responsiveness. PlexusDx's Precision Peptide Genetic Test identifies genetic variants in pathways like GLP1R and MC4R that help explain why certain patients thrive at different dose levels, enabling more targeted treatment planning from the start.
Dose Adjustments and Stopping Rules
If you experience significant nausea, vomiting, or other side effects during dose escalation, your prescriber may pause advancement, repeat the current dose for an extra week, or adjust the timing between doses. Dose adjustments are made based on your tolerance, not on a fixed schedule. Some patients skip a dose increment and stay at a lower maintenance level if they're experiencing good weight loss and feeling well. This flexibility is a core principle of personalized weight loss therapy—your dose should match your body's needs, not a predetermined protocol.
Conversely, if you've plateaued in weight loss or notice diminished appetite suppression after several weeks at a maintenance dose, your provider may recommend advancing to the next level. This decision typically comes after at least 4 weeks of stability at your current dose. Dose reductions are less common but may occur if side effects emerge after months of stable use or if your clinical situation changes. Throughout this process, PlexusDx maintains flat monthly pricing regardless of dose level, eliminating financial barriers to finding your optimal therapeutic dose.
Why Average Doses Vary: Genetics and Personalization
Your genetics significantly influence the dose of semaglutide that works best for you. Variants in the GLP1R gene (such as rs6923761) affect how efficiently your GLP-1 receptors respond to the medication, meaning some people achieve appetite suppression at lower doses while others need higher doses for the same effect. Similarly, GIPR variants and MC4R polymorphisms influence your baseline appetite regulation and satiety signals, further personalizing your ideal dose. These genetic differences are not good or bad—they simply explain why one person's effective dose may be another person's insufficient dose.
PlexusDx's Precision Peptide Genetic Test maps 14 appetite and metabolism pathways, analyzing 49 peptides and 150+ genetic insights to identify your individual dose response patterns before you begin treatment. This test costs $99 and can be added after your first month of therapy, allowing your prescriber to refine your dose trajectory with genetic insights rather than guessing. Patients who understand their genetic predispositions often feel more confident in their treatment plan and experience faster optimization to their ideal dose. This precision approach transforms semaglutide from a one-size-fits-all therapy into a truly personalized weight loss medication.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected subcutaneously once per week. This low initial dose allows your body to adjust to GLP-1 receptor activation before advancing to higher doses over the following weeks. PlexusDx delivers compounded semaglutide injections starting at $149 per month, with the same flat price whether you're at 0.25 mg or a higher maintenance dose.
What is the average maintenance dose most people end up using?
Clinical evidence shows most patients achieve optimal results at maintenance doses between 1.0 mg and 2.4 mg weekly, with 1.7 mg and 2.4 mg being common long-term doses in published trials. However, some individuals respond well to 0.5 mg or 1.0 mg, while others may require higher doses. Your individual response determines your ideal maintenance dose, not an arbitrary average.
Does the price of PlexusDx semaglutide increase with higher doses?
No. PlexusDx charges a flat monthly rate of $149 per month for compounded semaglutide injections across all dose levels. Your dose may need to go up as your treatment progresses, but your price stays the same, making dose optimization financially predictable and affordable.
What happens if I don't lose weight at my current dose?
If you've been stable at your current dose for at least 4 weeks without meaningful weight loss, your provider may recommend advancing to the next dose level. Some patients also benefit from lifestyle modifications or evaluation for other factors affecting weight loss. If side effects prevent dose increases, alternative formulations like oral semaglutide or a lower-dose microdose protocol may be considered.
How can genetic testing help determine my ideal semaglutide dose?
PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence your dose response and appetite regulation. Understanding your genetic predispositions helps your provider anticipate whether you'll likely respond to lower doses or require higher doses, enabling faster optimization and better outcomes. The test costs $99 and can be added after your first month of treatment.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Does Zepbound Do for Weight Loss?
How Much Weight Loss Can You Expect with Zepbound in the First Month?